INSIGHT REPORT CALENDAR

NEWSLETTER

Like this article?

Sign up to our free newsletter

Illumina Ventures expands European team

Illumina Ventures, an independently-managed, healthcare-focused venture firm in a strategic partnership with Illumina, has added four new members to its European team.

Arnaud Autret, PhD, MSc, will be principal and head of European operations, William Byrne, PhD, be an associate – Europe, and Ronan Byrne and Ivan Coulter, PhD, BSc, will serve as venture advisors – Europe.

Autret brings more than 15 years of financial and investment experience in the life sciences and biopharmaceutical industries, as well as scientific knowledge, to his new position. Before joining the Company, Arnaud was Investment Director in the biotechnology team of M Ventures in Amsterdam, which is the corporate venture capital arm of Merck KGaA. 

Before joining Illumina Ventures, Byrne was Head of Biotechnology at NEOM, a futuristic megacity that will be located in Saudi Arabia and rely on renewable energy and new technology for sustainable living. Byrne led the efforts to establish NEOM as a global biotech hub with a focus on precision medicine. 

As a highly experienced CEO, Byrne has built and led several companies over his career that he later sold to multinational companies. Over the last decade, he has focused his efforts on the commercialisation of innovations in the life sciences industry. 

Coulter is an entrepreneur with experience in translating early-stage innovations into clinical development programs. As a pharmacologist, he understands the importance of aligning molecular pathways with appropriate therapeutics and diagnostics. He is currently Founder and Managing Director of Eden BioPharma Limited in Dublin.

Like this article? Sign up to our free newsletter

FEATURED

Tech Stocks

MOST RECENT

FURTHER READING